Nanovibronix Inc
NAOV
View Detailed Chart
6.110USD
-0.215-3.40%
Market hours （ET）Quotes delayed by 15 min
481.08KMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-3.40%
5 Days
-12.59%
1 Month
+13.25%
6 Months
+43.76%
Year to Date
-5.86%
1 Year
-10.41%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-24Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 240.16% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 2.56M.
Overvalued
The company’s latest PE is -0.03, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 142.96K shares, increasing 35.89% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.99.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
Ticker SymbolNAOV
CompanyNanovibronix Inc
CEODr. Doron Besser, M.D.
Websitehttps://nanovibronix.com/
Related Instruments
-1.48%
-1.32%
-1.01%
-2.19%
-0.15%
+0.74%
-2.82%
-2.38%
-4.22%
-3.05%
-1.37%
-1.14%
-2.56%
-1.94%
-1.00%
-1.87%
-3.08%
+1.16%
-2.84%
-1.03%
